This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Catalano, M. Articles by Libretti, A. Search for Related Content PubMed PubMed Citation Articles by Catalano, M. Articles by Libretti, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-PROLINE CAPTOPRIL Medline Plus Health Information High Blood Pressure Vascular Diseases Social Bookmarking                         What's this?

Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease

Clinica Medica Generale Università degli Studi di Milano Ospedale "L. Sacco" Milan, Italy

A. Libretti

Clinica Medica Generale Università degli Studi di Milano Ospedale "L. Sacco" Milan, Italy

Many epidemiological studies have shown up the frequent association of ar terial hypertension (HT) with atherosclerosis of different localizations. How ever, many of the drugs used to treat HT are contraindicated in patients with peripheral vascular disease (PVD), because they cause unfavorable metabolic changes or vasoconstriction.

The aim of the present study was to assess the effect of a proven hypotensive drug, captopril, on the peripheral circulation. The drug appeared to be effec tive in improving blood flow to lower limbs, prolonging the pain. Free interval and increasing the angle/arm arteral pressure index.

Angiology, Vol. 36, No. 5, 293-296 (1985)
DOI: 10.1177/000331978503600505


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. T Hirsch and D. Duprez The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease Vascular Medicine, November 1, 2003; 8(4): 273 - 278. [Abstract] [PDF]

				D. H. Roberts, Y. Tsao, K. Linge, G. A. McLoughlin, and A. Breckenridge Double-Blind Comparison of Captopril with Nifedipine in Hypertension Complicated by Intermittent Claudication Angiology, September 1, 1992; 43(9): 748 - 756. [Abstract] [PDF]